ISE Chemicals Corporation

ISE Chemicals Corporation

ICHMF
ISE Chemicals CorporationUS flagOther OTC
26.60
USD
+23.32
- -
1.36BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
311.4
353.59
347.52
278.63
281.22
306.18
330.54
330.63
399.25
501.45
518.21
653.25
770.38
573.09
Basic EPS, GAAP
40.28
42.13
25.82
13.81
2.14
11.33
23.36
26.34
34.78
50.25
72.04
99.52
127.51
79.99
Free Cash Flow per Basic Share
0.63
1.66
43.65
8.11
26.44
20.08
12.3
-4.41
-0.18
0.84
48.32
13.01
95.15
- -
Dividend per Share
7.99
8.99
8.99
8.48
7
6
6.49
7.98
9.98
14.5
21.99
31.99
38.99
- -
Book Value per Share
341.91
375.13
392.05
326.93
392.71
398.2
415.14
433.5
458.38
494.15
544.3
611.98
700.47
572.81
Tangible Book Value per Share
403.99
444
460.91
464.77
458.19
459.75
473.86
493.31
521.97
561.84
613.97
685.4
767.15
646.62
Basic Weighted Avg Shares
51
51
51
51
51
51
51
51
51
51
51
51
51
51
Sales/Revenue/Turnover
15,902
18,052
17,738
14,219
14,348
15,615
16,854
16,859
20,354
25,564
26,413
33,287
39,258
29,188
Operating Margin (%)
23.93
21.7
13.1
7.54
2.84
10.12
12.21
12.97
13.31
14.7
20.05
23.01
24.16
21.4
Depreciation Expense
1,274
1,331
1,693
1,661
1,666
1,399
1,356
1,311
1,489
1,812
1,970
1,975
2,046
- -
Net Income, GAAP
2,057
2,151
1,318
705
109
578
1,191
1,343
1,773
2,562
3,672
5,071
6,498
4,074
Effective Tax Rate (%)
36.92
37.7
36.45
31.78
60.57
41.68
34.27
32.43
31.56
28.79
29.37
31.56
28.97
31.11
Profit Margin (%)
12.94
11.92
7.43
4.96
0.76
3.7
7.07
7.97
8.71
10.02
13.9
15.23
16.55
13.96
Working Capital
11,346
11,899
12,819
13,292
13,723
13,767
14,150
13,998
13,745
15,198
17,335
19,896
23,304
18,372
LT Debt
22
13
9
11
18
12
14
18
19
21
37
37
41
- -
Total Equity
21,058
23,095
23,933
24,094
23,725
23,948
24,715
25,680
27,129
29,218
31,890
35,568
40,069
33,589
Return on Invested Capital (%)
11.26
10.41
6
2.95
0.65
3.72
5.32
5.63
6.76
9.1
11.65
14.68
16.83
12.77
Return on Capital (%)
11.92
11.37
6.53
3.72
0.58
2.78
5.58
6.04
7.59
10.29
13.55
16.87
19.12
14.34
Return on Common Equity (%)
12.36
11.75
6.73
3.84
0.59
2.87
5.74
6.21
7.8
10.55
13.87
17.21
19.43
14.64

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
619
600
600
LT Borrowings
- -
- -
- -
LT Finance Leases
37
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
51
51
Market Capitalization
23,593
25,300
26,892

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
24,141
22,662
25,344
Cash, Cash Equivalents & STI
9,720
8,091
8,686
Accounts Receivable, Net
6,692
6,324
7,635
Inventories
7,595
8,153
8,887
Total Current Liabilities
6,806
5,375
6,972
Payables & Accruals
- -
- -
- -
ST Debt
619
600
600
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.38%
9.33%
12.65%
Free Cash Flow
545.81%
1,102.48%
631.37%
Net Income, GAAP
60.41%
37.22%
28.14%
Sales/Revenue/Turnover
9.15%
18.72%
17.94%
Total Cash Common Dividend
18.29%
37.85%
21.9%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
5,138
7,421
6,431
7,423
26,413
2024
6,857
8,477
- -
- -
33,287
2025
- -
- -
- -
- -
39,258

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
13.24
- -
- -
- -
72.04
2024
17.18
- -
- -
- -
99.52
2025
- -
- -
- -
- -
127.51

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
21.99
2024
- -
- -
- -
- -
31.99
2025
- -
- -
- -
- -
38.99

Company Description

APIChat
CEO
Tadashi Hiraoka
Full Time Employees
325
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
Yaesuguchi Daiei Building Tokyo Japan 104-0031
IPO Date
Jan 31, 2022
Business
ISE Chemicals Corporation engages in the manufacture and sale of chemical products primarily in three core segments: iodine and iodine compounds; natural gas; and metallic compounds. The iodine product line includes prilled iodine (ISEFLO), crude iodine, potassium iodide, sodium iodide, cuprous iodide, hydroiodic acid, and iodine disinfectants marketed under the ISEPHOR, DIASAN CLEAN, and ISEPHOR L brands. These iodine products serve diverse applications in the medical field (such as mouthwash and contrast media), livestock feed additives, disinfectants, agricultural chemicals, automotive safety (airbags and seat belts), and electronic devices including LCDs and developing next-generation semiconductors. The metallic compounds segment offers nickel chloride and cobalt hydroxide used in electronic components and ceramic capacitors essential for compact, high-functionality electronic equipment like smartphones and advanced automobiles. The natural gas segment involves extraction and sale operations related to natural gas. Founded in 1927 and headquartered in Tokyo, Japan, ISE Chemicals operates primarily in Japan with products catering to industrial, agricultural, medical, and consumer markets. In recent developments, ISE Chemicals has reported robust financial results with significant revenue growth in the iodine and natural gas business, reflecting heightened global demand amid agricultural and industrial challenges. The company has been actively investing in research and development to enhance product quality and expand applications, including advancing materials for electronics and semiconductor innovations. In 2024 and 2025, the company has undertaken strategic equity buybacks, signaling confidence in its financial position, and its shares have experienced notable appreciation based on strong earnings growth and positive market sentiment. These operational and financial enhancements demonstrate ISE Chemicals' commitment to sustainable growth and expanding its market presence in specialty chemicals with a focus on innovation and environmental stewardship. ISE Chemicals Corporation continues to strengthen its position in the specialty chemicals industry by leveraging its longstanding expertise in iodine-related products, metallic compounds, and natural gas resources, aligning its business strategy with global industry trends and customer needs in Japan and beyond.